Literature DB >> 20939120

Science of weight loss supplements: compromised by conflicts of interest?

Ano Lobb.   

Abstract

Weight loss supplements often contain powerful pharmacoactive ingredients with the potential to cause harm. Trials used to determine product safety and effectiveness, meanwhile, tend to be small, of short duration, and frequently lack financial conflict of interest disclosures. These factors could conspire to place consumers at risk, especially when published research cited in advertising cloaks products with the suggestion that their safety and effectiveness have been proven by science. Examples of current and former weight loss products backed by potentially conflicted or low quality research include Metabolife-356, Hydroxycut, Xenadrine and LeptiCore. Published research, especially in the field of weight loss supplements, needs better conflict of interest disclosure, and regulators should consider how research findings are used in marketing claims.

Entities:  

Mesh:

Year:  2010        PMID: 20939120      PMCID: PMC2955261          DOI: 10.3748/wjg.v16.i38.4880

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  HCA efficiency.

Authors:  S B Heymsfield; L J Aronne; G L Blackburn
Journal:  Diabetes Obes Metab       Date:  2004-11       Impact factor: 6.577

2.  Enhancing FDA's post-market surveillance of dietary supplements: two simple steps to build capacity.

Authors:  Ano Lobb
Journal:  J Diet Suppl       Date:  2009

3.  The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Wolf-Dieter Ludwig; Klaus Lieb
Journal:  Dtsch Arztebl Int       Date:  2010-04-23       Impact factor: 5.594

Review 4.  Adverse events of herbal food supplements for body weight reduction: systematic review.

Authors:  M H Pittler; K Schmidt; E Ernst
Journal:  Obes Rev       Date:  2005-05       Impact factor: 9.213

5.  An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial.

Authors:  C N Boozer; J A Nasser; S B Heymsfield; V Wang; G Chen; J L Solomon
Journal:  Int J Obes Relat Metab Disord       Date:  2001-03

6.  Weight loss and delayed gastric emptying following a South American herbal preparation in overweight patients.

Authors:  T Andersen; J Fogh
Journal:  J Hum Nutr Diet       Date:  2001-06       Impact factor: 3.089

7.  The use of LeptiCore in reducing fat gain and managing weight loss in patients with metabolic syndrome.

Authors:  Dieudonne Kuate; Blanche C O Etoundi; Boris K G Azantsa; Anne-Pascale N Kengne; Judith L Ngondi; Julius E Oben
Journal:  Lipids Health Dis       Date:  2010-02-19       Impact factor: 3.876

8.  Do pressures to publish increase scientists' bias? An empirical support from US States Data.

Authors:  Daniele Fanelli
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

Review 9.  A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity.

Authors:  Shirin Hasani-Ranjbar; Neda Nayebi; Bagher Larijani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

10.  Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss.

Authors:  H G Preuss; D Bagchi; M Bagchi; C V S Rao; D K Dey; S Satyanarayana
Journal:  Diabetes Obes Metab       Date:  2004-05       Impact factor: 6.577

View more
  3 in total

1.  Science in liquid dietary supplement promotion: the misleading case of mangosteen juice.

Authors:  Ano L Lobb
Journal:  Hawaii J Med Public Health       Date:  2012-02

2.  Persistent danger from weight loss supplements.

Authors:  Ano L Lobb
Journal:  Hawaii Med J       Date:  2011-03

3.  What's new about inflammatory bowel diseases in Ischemic colitis induced by the newly reformulated multicomponent weight-loss supplement Hydroxycut(®).

Authors:  Muhammed Sherid; Salih Samo; Samian Sulaiman; Joseph H Gaziano
Journal:  World J Gastrointest Endosc       Date:  2013-04-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.